Read More 2 minute read Pharma Industry News Trovagene’s Onvansertib-decitabine combination trial shows promising results Trovagene, a California-based cancer research company, has announced the successful completion of the second dosing cohort in its… bypharmanewsdailySeptember 29, 2018
